<DOC>
	<DOCNO>NCT01521663</DOCNO>
	<brief_summary>The purpose study determine whether IPX159 safe effective treating symptom RLS subject Restless Legs Syndrome .</brief_summary>
	<brief_title>Safety Efficacy Study IPX159 Restless Legs Syndrome ( RLS )</brief_title>
	<detailed_description>IPX159 develop extended release formulation reduce fluctuation nefopam concentration compare IR reduce incidence peak rate relate side effect .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<criteria>1 . Able understand willing sign inform consent form ( ICF ) Health Insurance Portability Accountability Act ( HIPAA ) authorization 2 . Males female age 1870 history primary RLS â‰¥6 month prior screen 3 . Symptoms RLS medical history least 15 night month prior Screening 4 . BMI 18.532 5 . Negative alcohol drug abuse screen 6 . Negative serum pregnancy test 7 . Agrees use medically acceptable method contraception throughout study 2 month complete study . 8 . Able willing comply protocol , include availability schedule clinic visit telephone call . 1 . Subjects use intend use post screening follow medication medication category : Sedative hypnotic , trazodone Dopamine agonists , gabapentin , gabapentin enacarbil , pregabalin Narcotic analgesic , opioids , tramadol , cyclobenzaprine Iron supplementation therapy 2 . History HIV , hepatitis B C 3 . Pregnant breastfeeding . 4 . History clinical sign form epilepsy seizure , exclude feverrelated seizure childhood . 5 . History presence glaucoma 6 . Planning take herbal medication ( eg , hypericum perforatum [ St John 's Wort ] , licorice , ephedra , ginkgo , ginseng ) study . 7 . Use investigational drug within last 30 day within period 5 time drug 's halflife , whichever longer 8 . Subjects , opinion Investigator , participate study capable follow study schedule reason 9 . Employees family member Investigator , study site , Sponsor , Contract Research Organization ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Moderate severe idiopathic RLS</keyword>
</DOC>